In April, patients and their families arrived at a meeting convened by the US Food and Drug Administration (FDA) near its headquarters in Maryland, anxious to hear whether the agency would approve a ...

The modulation of RNA splicing by small molecules has emerged as a promising strategy for treating pathogenic infections, human genetic diseases, and cancer; however, the principles by which splicing ...